Comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 vs 3 4 Metacarpal Synostosis C5558402
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Endogenous Maternal Derived Androgen and 3 4 Metacarpal Synostosis for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
A condition where hormones from the mother cross the placenta and cause atypical development in an XX fetus. It is present at birth. Management involves pediatric specialists and may include hormone therapy.
3 4 Metacarpal Synostosis C5558402
Two hand bones (metacarpals) are fused together from birth. May reduce grip strength and affect hand appearance. Management is personalized based on severity.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Variable
3 4 Metacarpal Synostosis C5558402
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
severe
3 4 Metacarpal Synostosis C5558402
mild
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Chronic
3 4 Metacarpal Synostosis C5558402
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
No
3 4 Metacarpal Synostosis C5558402
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
reproductive
3 4 Metacarpal Synostosis C5558402
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
endocrine
3 4 Metacarpal Synostosis C5558402
other
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-endogenous-maternal-derived-androgen-C5679875 and 3-4-metacarpal-synostosis-C5558402 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3 4 Metacarpal Synostosis C5558402 | Discriminating power |
|---|---|---|---|
| Sex development | Atypical development may be present at birth in an XX fetus after maternal androgen exposure. | Hand-bone fusion does not itself indicate atypical sex development. | High |
| Hand structure and grip | No metacarpal fusion is described for this condition. | Third and fourth metacarpals are fused from birth; grip may be reduced. | High |
| Endocrine context | Linked to maternal-derived androgen; specialist endocrine review may be relevant. | Described as a localized musculoskeletal finding without an endocrine cause. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 when
Atypical genital development with possible maternal androgen exposure
This matches the supplied reproductive and endocrine description.
Moderate
Need for pediatric DSD or endocrine specialist input
Source management involves pediatric specialists and may include hormone therapy.
Moderate
The concern is sex development rather than hand anatomy
The assigned body system is reproductive, not musculoskeletal.
High
Choose 3 4 Metacarpal Synostosis C5558402 when
Congenital fusion of the third and fourth metacarpals
This is the defining finding in the supplied description.
High
Mild concern about grip or hand appearance
Severity is labeled mild, with possible reduced grip and altered appearance.
Moderate
No genital or endocrine findings are described
The source presents a localized congenital hand condition.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3 4 Metacarpal Synostosis C5558402 | Interpretation |
|---|---|---|---|
| Sex-chromosome assessment | May support 46,XX status but does not prove the androgen mechanism. | Not expected to explain metacarpal fusion. | Chromosome results require specialist interpretation and are not a complete diagnosis. |
| Endocrine evaluation | Hormone assessment may be considered; no cutoff is established here. | Not indicated by the hand finding alone. | An abnormal hormone result is not itself a diagnosis. |
| Hand radiograph | No characteristic metacarpal fusion is described. | May show fusion of the third and fourth metacarpals. | Imaging supports the skeletal finding but needs clinical correlation. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
- Outcome
- Long-term outcome is not established; the source labels it severe and chronic.
- Factors
- Specialist care and individual endocrine findings may influence management, but outcomes are not quantified.
3 4 Metacarpal Synostosis C5558402
- Outcome
- Often described as mild and chronic, with possible grip or appearance effects.
- Factors
- Severity and functional impact guide personalized care; prognosis is not quantified.
Time frame: Both are described as present from birth or early life and chronic; exact course is not established.
Body system, severity label, and individual findings differ; clinician follow-up is needed.
Complications comparison
| Complication | Presentation |
|---|---|
| Psychosocial impact | Distress related to sex development and care is possible; extent is not established. Concern about appearance or hand function is possible. Impact varies and should be assessed individually. |
| Functional limitation | Specific functional effects beyond atypical development are not established. Grip strength may be reduced. Neither outcome is quantified in the source. |
| Care burden | Specialist follow-up and possible hormone therapy may be needed; doses are not specified. Management is personalized by severity; surgery is not established here. Treatment decisions require clinician judgment. |
Patient education highlights
- HighDifferent conditions
These conditions affect different body systems and are not alternatives for one another.
- HighSpecialist interpretation
A test abnormality or birth finding needs clinician review before any diagnosis or treatment.
- MediumLimits of available information
Prevalence, exact cutoffs, mortality, and treatment doses are not established by this source.